| Literature DB >> 33443614 |
Annegrit Decker1, Christoph Neumann-Haefelin1, Robert Thimme2.
Abstract
Hepatitis viruses A-E cause acute and chronic liver inflammation and thus lead to significant morbidity and mortality worldwide. They differ significantly in their biology, course of disease and therapy options. While hepatitis A virus only causes acute infection, hepatitis B can become chronic, even reactivate or occur as coinfection with hepatitis D virus. Whereas these infections are preventable through vaccination, a vaccine does not exist against HCV. However, new direct antiviral agents reliably lead to cure of chronic hepatitis C. Hepatitis E virus frequently causes acute or-in case of immunosuppression-even chronic hepatitis. Continual screening of patients with elevated liver enzymes or risk groups using simple serological markers can enable virus-specific therapy of mostly asymptomatic chronic virus hepatitis, preventing the development of liver cirrhosis and hepatocellular carcinoma.Entities:
Keywords: Antiviral agents, direct acting; HBV reactivation; Hepatitis, acute; Hepatitis, chronic; Liver cirrhosis
Year: 2021 PMID: 33443614 DOI: 10.1007/s00108-020-00923-9
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743